CRDF
Price:
$0.81
Market Cap:
$53.16M
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, metastatic triple negative breast cancer, and chronic myelomonocytic leukemia; CRDF-004, a Phase 2 open-label randomized multi-center clinical trial of onvansertib in combination with FOLFIRI and bevacizumab or FOLFOX and bevacizum...[Read more]
Industry
Biotechnology
IPO Date
2004-07-27
Stock Exchange
NASDAQ
Ticker
CRDF
According to Cardiff Oncology, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Cardiff Oncology, Inc. over the last ten years is 91.88%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), CRDF's Dividend Yield was at its highest in in the December 2019 quarter at 234.70%. The Dividend Yield was at its lowest in in the June 2016 quarter at 0%.
Average
91.88%
Median
0.34%
Minimum
0%
Maximum
327.23%
Discovering the peaks and valleys of Cardiff Oncology, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 327.23%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0% | 0% |
| 2024 | 0% | 0% |
| 2023 | 0% | -100.00% |
| 2022 | 0.68% | 6.53% |
| 2021 | 0.01% | Infinity% |
| 2020 | 0% | -100.00% |
| 2019 | 327.23% | 0.03% |
| 2018 | 327.13% | 45.09% |
| 2017 | 225.47% | 489.42% |
| 2016 | 38.25% | 123.29% |
The current Dividend Yield of Cardiff Oncology, Inc. (CRDF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0.14%
10-year avg
91.88%
Cardiff Oncology, Inc.’s Dividend Yield is less than Applied Therapeutics, Inc. (0%), less than Corbus Pharmaceuticals Holdings, Inc. (0%), less than Elicio Therapeutics, Inc. (0%), less than Molecular Partners AG (0%), less than Forte Biosciences, Inc. (0%), less than PepGen Inc. (0%), less than Rani Therapeutics Holdings, Inc. (0%), less than Milestone Pharmaceuticals Inc. (0%), less than Cassava Sciences, Inc. (0%), less than Innate Pharma S.A. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $14.86M | |
| 0% | $165.27M | |
| 0% | $55.10M | |
| 0% | $147.42M | |
| 0% | $1.57B | |
| 0% | $118.28M | |
| 0% | $55.12M | |
| 0% | $89.32M | |
| 0% | $63.77M | |
| 0% | $170.90M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cardiff Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cardiff Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Cardiff Oncology, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Cardiff Oncology, Inc. (CRDF)?
What is the highest Dividend Yield for Cardiff Oncology, Inc. (CRDF)?
What is the 3-year average Dividend Yield for Cardiff Oncology, Inc. (CRDF)?
What is the 5-year average Dividend Yield for Cardiff Oncology, Inc. (CRDF)?
How does the current Dividend Yield for Cardiff Oncology, Inc. (CRDF) compare to its historical average?